Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Michael B Sheffery
AddedMar 31, 2024
UpdatedMay 31, 2026
Michael B Sheffery

Michael B Sheffery

Co-Founder, OrbiMed Advisors

Crunchbase

Michael B Sheffery's Career

OrbiMed Advisors
OrbiMed Advisors

New York City, NY, US

Co-Founder
Cogenesys
Cogenesys

Rockville, MD, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Michael B Sheffery's Career

OrbiMed Advisors
OrbiMed Advisors
Investment FirmInvestment Firm1001989New York City, NY, US
Co-Founder

Leadership at OrbiMed Advisors

Sam IsalySam IsalyBoard Member

Similar to OrbiMed Advisors

Orbit Venture PartnersOrbit Venture PartnersMenlo Park, CA, USest. 2019Orbit Venture PartnersMenlo Park, CA, US · est. 2019

Orbit Venture Partners: A Menlo Park-based financial services and investment firm.

Investment Firm50
Global BioAccess FundGlobal BioAccess FundNew York City, NY, USest. 2021Global BioAccess FundNew York City, NY, US · est. 2021

Global BioAccess Fund: Investing in transformative medical startups for unmet needs, based in NY.

Investment Firm4
ORI CapitalORI CapitalWanchai, Wan Chai, HKest. 2015ORI CapitalWanchai, Wan Chai, HK · est. 2015

ORI Capital: A global venture capital firm specializing in healthcare investments since 2015.

Investment Firm20
Orion Healthcare Equity PartnersOrion Healthcare Equity PartnersBoston, MA, USest. 2007Orion Healthcare Equity PartnersBoston, MA, US · est. 2007

Investing in health innovations for a better future.

Investment Firm6
Cogenesys
Cogenesys
Acquired$55M02005Rockville, MD, US
Board Member· Board

Leadership at Cogenesys

Chuck NewhallChuck NewhallBoard Member
Phd BarrettPhd BarrettBoard Member
Bradley G Lorimier \"Brad\"Bradley G Lorimier \"Brad\"Board Member
Craig A RosenCraig A RosenBoard Member
Steven MayerSteven MayerBoard Member

Similar to Cogenesys

Cogent BiosciencesCogent BiosciencesWaltham, MA, USBiotech, Therapiesest. 2014Cogent BiosciencesWaltham, MA, US · est. 2014

US-based Cogent Biosciences develops biotech solutions for genetically driven diseases.

Public · $692.7M138
ConagenConagenBedford, MA, USBiochemicals, Ingredientsest. 2010ConagenBedford, MA, US · est. 2010

US-based Conagen is a biotech firm specializing in bio-production of ingredients for food, pharma, and renewable materials.

Series C · $30.2M52
GeneicdGeneicdScottsdale, AZ, USBiotechnology, Genomicsest. 2019GeneicdScottsdale, AZ, US · est. 2019

GENEICD: A leading biotech firm innovating in genomics for improved patient health.

Seed · $152.5k7
Generation BioGeneration BioCambridge, MA, USGenetic Medicinesest. 2016Generation BioCambridge, MA, US · est. 2016

Generation Bio Co.: A US-based biotech firm specializing in genetic medicines for systemic and hepatic diseases.

Public · $536.4M150

Michael B Sheffery's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Michael B Sheffery

Carl L. GordonCarl L. GordonBoard Member · Terns PharmaceuticalsMike PapeMike PapeCo-Founder · Orchard Venture PartnersRishi GuptaRishi GuptaBoard Member · Aer TherapeuticsQ Khuong ChauQ Khuong ChauBoard Member · NextCureScott NolanScott NolanPartner · Founders Fund